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Sumatran lichen has the potential as antiviral, pure isolates that have been isolated and 
developed as prospective compounds for COVID-19 treatment. Computational methods were used to 
accelerate the discovery and screening of potential new compounds. The molecular structures of the 
isolated compounds such as Lobarin, Atranorin, Methyl 2,4-dihydroxy-3,6-dimethylbenzoate, Methyl 
3‐formyl‐2,4‐dihydroxy‐6‐methylbenzoate, Ethyl 3-formyl-2,4-dihydroxy-6-methylbenzoate, and 
Lobaric acid were drawn, then their activities were analyzed, processed by docking with ACE2 
protein, and tested for Druglikeness. The activities and druglikeness were determined in the Swiss 
ADME program, while the ACE2 docking was processed by Blind Docking in Arguslab, AutoDock 
Vina, Open Babel, and Discovery Studio Visualizer programs. All compounds bound to the ACE2 
protein, as apparent from the number of hydrogen bonds between the two. The Gibbs free energy was 
in the range of -5.6 to -7.0, and the best one was obtained from atranorin. As for lobarin, this 
compound was found to be non-drug-like. 
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The COVID-19 disease has turned into a worldwide pandemic, with 11,799,443 positive cases 
and 543,558 fatalities per July 8, 2020, with a fatality rate of 4.6% (Hopkins, 2020). Every country 
has, therefore, applied different techniques to contain the spread, including quarantine and travel 
restrictions in China, Italy, Spain, India, and Iran and mass testing in South Korea (Dunford et al., 
2020). 
COVID-19 enters through the pathway of the ACE2 receptor (Wan et al., 2020). ACE2 is 
presented in type II alveolar epithelial cells, which are the entry point of the SARS-COV2 virus (Zhao 
et al., 2020). High mortality factors are prevalent in patients with congenital diseases, such as 
hypertension, diabetes, and heart disease. Understanding the pathway of the virus is a stepping stone to 
the development of drugs that specifically target ACE2. 
A lichen, another name of crust moss, is a plant that emerges from the symbiotic relationship 
between fungi (mycobionts) and algae and grows in tree trunks, soil, rocks, foreshore, and mountain 
cliffs (Ranković, 2015). Prior scholars have confirmed the antiviral potential of this plant (Odimegwu 
et al.,  2015). For this reason, this study used Stereocaulon halei (Sumatran lichen), a biotic material 
native of Indonesia, to identify its potential for treating COVID-19 disease by computational methods 
and molecular simulations. 
The active compounds contained in S. halei were investigated by Absorption, Distribution, 
Metabolism, and Excretion (ADME). ADME prediction can simulate the process of drugs in the body. 
Toxicity testing provides structural alerts that indicate whether or not the compound observed can 
cause carcinogens and mutagens. Docking is a simulation method used to determine the orientation 
between ligands and receptors. Compounds from S. halei are docked in the ACE2 protein of the 
SARS-COV2 virus. 
This research employed a blind docking process because the grid box parameters of the 
Angiotensin-converting enzyme 2 (ACE2) enzyme were unknown. The docking process was semi-
flexible, in which the receptors used were rigid, while the ligands were flexible. AutoDock Vina is one 
of the docking programs designed to predict small molecules such as inhibitors attached to receptors in 
the form of three-dimensional (3D) structures. Basically, AutoDock Vina consists of two main 
features, which are AutoDock that helps the docking process of ligands to a set of grids that represents 
the intended protein and AutoGrid that helps the calculation of the grids. A computational method is 
expected to find prospective natural substance-based drugs for COVID-19 disease. 
 
MATERIALS AND METHODS 
Materials 
The materials used were the chemical structures of the six compounds isolated from 
Stereocaulon halei, namely (1) Lobarin, (2) Atranorin, (3) Methyl 2,4-dihydroxy-3,6-
dimethylbenzoate, (4) Methyl 3‐formyl‐2,4‐dihydroxy‐6‐methylbenzoate, (5) Ethyl 3-formyl-2,4-
dihydroxy-6-methylbenzoate, and (6) Lobaric acid. Figure 1 presents the structures of these 
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Figure 1. The structures of the compounds isolated from Stereocaulon halei (Sumatran lichens) 
 
 
Software and hardware 
The tools used in this study were computers with Intel® Core (TM) i5-2450 M CPU @ 2.50 
GHz and Intel® Atom ™ X5-Z8300 CPU @ 1.44GHz (4CPU). The operating systems were Windows 
7 and 10 64-Bit. The software used included Marvin Sketch v.16.9.12, OECD QSAR Toolbox v.4.3, 




ADME and toxicity 
The 2D structure was drawn in the Marvin Sketch program, and the compound was analyzed 
according to the name listed in the International Union of Pure and Applied Chemistry (IUPAC). The 
protonation was adjusted at pH 7.4, which is the normal condition of the human body. Then, the 
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chemical structure was analyzed by SwissADME (Absorption, Distribution, Metabolism, and 
Excretion). As for the toxicity, it was predicted using the structural alert feature provided in QSAR 
Toolbox. 
 
Ligands and proteins 
The materials used were the 3D macromolecular structures of Angiotensin-converting enzyme 2 
(ACE2) (PDB ID: 6M17), obtained from the online database of Protein Data Bank (www.pdb.org), 
and compounds isolated from Stereocaulon halei. 
 
Ligand preparation 
The ligands used were the isolated compounds of Stereocaulon halei. Their 3D structures were 
built and processed by the semi-empirical method (PM3) geometry optimization using the Arguslab 




The ACE2 macromolecules (GDP: 6M17) were downloaded from the protein data bank (GDP) 
website, www. rcsb.org. The structure of this protein was displayed in the Discovery Studio Visualizer 
v.4.5 program package, separated from the water molecules and their natural ligands, then stored in 
*.pdb and treated as a receptor. 
 
Molecular simulation 
Subsequently, the test compounds were tethered in the receptor using the blind docking method. 
This method was used because the test receptors were categorically new, still in the process of 
research and development, and, therefore, had no congenital ligands. Besides, the active side of ACE2 
was unknown. The molecular docking was carried out using the AutoDock Vina program. The results 
of the analysis were free energy bonds, hydrogen bonds, and binding patterns with other amino acid 
residues at the test receptors. 
 
RESULTS AND DISCUSSION 
Predictions of the chemical-physical properties 
The predicted chemical-physical properties of the pure compounds of Stereocaulon halei were 
presented in Table 1. These properties included the predicted values of the molecular weight, molar 
refractivity, topology surface area (TPSA), log p, and log S. 
 




 Log p Log S  




1 474.50 122.30 145.58 3.85 -8.52 
2 374.34 95.48 130.36 2.78 -6.78 
3 196.20 51.70 66.76 1.77 -3.38 
4 210.18 52.12 83.83 1.26 -3.38 
5 224.21 56.93 83.83 1.61 -3.76 
6 455.48 120.26 122.19 4.33 -8.46 
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All compounds had molecular masses in the range of 196.20-474.50 g/mol. An orally 
administered drug can be easily absorbed if the molecular mass is less than 500 g/mol (Lipinski, 
2004). Molar refractivity is a measure of the steric factor, i.e., the volume occupied by an atom or 
group of atoms. It is used as a measure of substituent steric influence in the Quantitative Structure-
Activity Relationship (QSAR) equation (Patrick, 2013). 
Topology Polar Surface Area (TPSA) is a 2D-QSAR descriptor that represents a relationship 
between ligands and specific targets (Prasanna and Doerksen, 2008). Molecules with TPSA values 
higher than 140 angstroms are inclined to permeate the cell membrane poorly (Pajouhesh and Lenz, 
2005). The same case applies to lobarin. 
The log p-value reflects the tendency of a fat-soluble compound. All compounds isolated from 
Stereocaulon halei had log p of <5, meaning that they can be easily absorbed through oral 
administration (Lipinski, 2004). Here, log p was the consensus value from various log p determination 
methods. Log S is the logarithm of water solubility. Based on the log S values, lobarin, atranorin, and 
lobaric acid were categorized as compounds with low water solubility. Meanwhile, methyl 2,4-
dihydroxy-3,6-dimethylbenzoate, methyl 3‐formyl‐2,4‐dihydroxy‐6‐methylbenzoate, and ethyl 3-
formyl-2,4-dihydroxy-6-methylbenzoate were identified as water-soluble compounds. 
 
Pharmacokinetic prediction, drug-likeness, and medicinal chemistry 
The pharmacokinetic model represents the relationship between chemical coordination in 
tissues, chemical calculations, and ADME processes (El-Masri, 2013). The predicted pharmacokinetic 
profiles of the compounds observed are summarized in Table 2. 
 










1 Low No No No Yes Yes No Yes  -5.14 
2 High No No No No No No No  -5.51 
3 High Yes No No No No No No  -5.84 
4 High No No No No No No No  -6.17 
5 High No No No No No No No  -5.99 
6 High No No No Yes Yes No Yes  -4.74 
Notes: 
GIA= gastrointestinal absorption 
BBB= blood-brain barrier 
Pgp-subtrate = P-glycoprotein substrates 
Log Kp= skin permeability coefficient 
 
After oral absorption, the drug permeates the gastrointestinal mucous membrane then enters the 
blood circulation (Hirtz, 1985). Lobarin had low absorption in the low gastrointestinal membrane, 
Lobarin had low absorption in the low gastrointestinal membrane, in which this compound is found at 
high levels in the blood. Also, lobarin has four OH groups that can decrease gastrointestinal 
absorption. Atranorin, Methyl 2,4-dihydroxy-3,6-dimethylbenzoate, methyl 
3‐formyl‐2,4‐dihydroxy‐6‐methylbenzoate, ethyl 3-formyl-2,4-dihydroxy-6-methylbenzoate, and 
lobaric acid had high gastrointestinal absorption, had high gastrointestinal absorption, in which these 
compounds exist in low concentrations in the blood.  
Methyl 2,4-dihydroxy-3,6-dimethylbenzoate was able to cross the blood-brain barrier (BBB) 
due to the presence of a methyl group in the para position. Compounds permeating BBB by diffusion 
through lipids have molecular weights of <400 Da and hydrogen bonds of <8 (Pardridge, 2012).  
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 P-glycoprotein substrates are one of the drug-carrying proteins that affect drug distribution. 
This process affects plasma P -glycoprotein substrates as a transmembrane pump, which pumps the 
substrate from within to outside the cell (Finch and Pillans, 2014).  
From the prediction above, lobarin and lobaric acid were metabolized in CYP2C19, CYP3A4, 
and CYP2C9. CYP1 and CYP4 families—cytochrome P450 enzymes—are involved in drug 
metabolism, and the specific CYP2C9, CYP2C19, CYP2D6, and CYP3A4 isoenzymes are classified 
into the phase 1 metabolism (Waller and Sampson, 2018). Lobarin, methyl 2,4-dihydroxy-3,6-
dimethylbenzoate, and lobaric acid contain alkyl groups that play a role in oxidation reactions. 
Atranorin, methyl 3‐formyl‐2,4‐dihydroxy‐6‐methylbenzoate, and ethyl 3-formyl-2,4-dihydroxy-6-
methylbenzoate have aldehyde groups that prompt reduction reactions. 
CYP2C19 contributes to the metabolism of drugs, such as antiepileptic (S-mephenytoin and 
diazepam), proton pump inhibitors (omeprazole), amitriptyline, citalopram, and propranolol (Grody, 
2018). CYP2C9 cytochrome is a vital drug metabolism enzyme in the human body and comprises 
around 18% of human microsomes (Lee et al., 2003). The metabolisms of nonsteroidal anti-
inflammatory drugs, losartan, tolbutamide, warfarin, and carbamazepine take place in CYP2C9 
cytochrome (Yuan et al., 2002). CYP3A4 is involved in about 50% oxidative metabolisms of HIV 
protease inhibitors, calcium channel blockers (nifedipine), hydroxymethylglutaryl inhibitors, 
coenzyme A reductase, antineoplastic drugs (cyclophosphamide, ifosfamide, docetaxel, paclitaxel, 
doxorubicin, etoposide, teniposide or vinca alkaloids), and the metabolisms of, among others, 
testosterone and aflatoxin (Georg Hempel, 2004). CYP3A4 is found most commonly in the liver, small 
intestine, and kidney (Thummel and Wilkinson, 1998). 
Lobaric acid had the highest log Kp, meaning that it has the slowest skin penetration rate among 
the other compounds. On the contrary, methyl 3‐formyl‐2,4‐dihydroxy‐6‐methylbenzoate had the 
lowest log Kp value or, in other terms, the fastest skin penetration rate. Log Kp is the logarithmic 
coefficient of skin permeability (Kp) expressed in cm/s. In this study, it was obtained using the 
quantitative structure-activity relationship (QSAR) method by modeling the influencing factors of skin 
permeability, including molecular mass, melting point, and the log value of the octanol-water partition 
coefficient (Chang et al., 2012). 
 
Table 3. The predicted drug-likeness and medicinal chemistry of compounds isolated from 
Stereocaulon halei 
Compound 
Drug-likeness Medicinal chemistry 







No, Xlogp3>5 0.56 0 Alert 0 Alert 4.42 







0.55 0 Alert 0 Alert 1.81 
4 Yes Yes 0.55 0 Alert Aldehyde 1.84 
5 Yes Yes 0.55 0 Alert Aldehyde 2.05 
6 Yes No, Xlogp3>5 0.56 0 Alert Phenol 4.11 
 
Drug-likeness is the balance of molecular and structural properties that determine whether or not 
a drug molecule is similar to a currently or previously used drug. This study used the drug-likeness 
analysis proposed by Egan (Pharmacia) and Muegge and bioavailability prediction. The results are 
presented in Table 3. The Egan’s drug-likeness estimation proved that Lobarin did not meet the 
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requirements of drug-likeness because its TPSA was above 131.6. Meanwhile, the Muegge’s drug-
likeness database showed that there were three compounds, including Lobarin, Methyl 2,4-dihydroxy-
3,6- dimethylbenzoate, and lobaric acid, that did not meet the requirements of drug-likesness because 
Lobarin and Lobaric Acid have log p values were greater than 5. Methyl 2,4- dihydroxy-3,6- 
dimethylbenzoate has molecular weights were less than 200 g/mol. Bayern also uses Muegge’s drug-
likeness method (Daina et al., 2017). 
The bioavailability values of the compounds were 0.55 and 0.56. Compounds No. 2,3,4, and 5 
had the bioavailability value of 0.55 and not negative charge (at pH 6); hence, the requirements of 
good medicine were met. Compounds No. 1 and 6, i.e., lobarin and lobaric acid, had the bioavailability 
value of 0.56, negative charge of -1 or -2 (at pH 6), and PSA between >75 and <150 Å2 (Martin, 
2005). 
No compounds were categorized into Pan-Assay Interference Compounds (PAINS). PAINS are 
compounds that exhibit specific targets and often give false-positive results (hit identification) in High 
Throughput Screening (HTS) screening (Koptelov et al., 2018). The Brenk filters, containing a 
database of 105 fragments (Brenk et al., 2008), aims to find structural alerts of potential toxic effects 
of the compound observed. Structural alerts are chemical structures that indicate the toxic nature of a 
compound, in which part of the structure that has mutagenic and carcinogenic potentials is identified. 
The aldehydic group can lead to the formation of a Schiff base with a primary amine. This is 
considered potentially genotoxic, as demonstrated in vivo by the ability to react with nucleobases 
without metabolic activation, interbase cross-links, and adducts formation (Speit et al., 2007) 
According to an in vitro test at the HGPRT locus of V79 Chinese hamster cells, phenol is reported to 
have mutagenic properties in the liver (Paschin and Bahitova, 1982). Based on the Brenk’s filters, 
atranorin contained structural alerts of aldehyde and phenol structural alerts; methyl 
3‐formyl‐2,4‐dihydroxy‐6‐methylbenzoate and ethyl 3-formyl-2,4-dihydroxy-6-methylbenzoate had 
structural alerts of aldehyde; and lobaric acid had structural alerts of phenol. 
The degree to which a compound is difficult to synthesize ranges between 1 (very easy) to 10 
(very difficult). Its determination takes into account the factors of complexity, such as macrocyclic, 
chiral center (Ertl and Schuffenhauer, 2009). Based on this degree, the most easily synthesized 
compound was compound No. 3, followed by 4,5,2,6, and then 1. 
 
Docking 
The docking simulation produced 20 docking poses with different binding energies that were 
mostly negative because of the presence of strong interaction. The Gibbs free energies identified in 
this study are presented in Table 4. 
 
Table 4. The Gibbs free energy (∆G) obtained from the docking simulation of 
compounds isolated from Stereocaulon halei  
Compounds Gibbs free energy 
Lobarin  -6.7  
Atranorin  -7.0 
Methyl 2,4-dihydroxy-3,6-dimethylbenzoate -5.9 
Methyl 3‐formyl‐2,4‐dihydroxy‐6‐methylbenzoate -5.9 
Ethyl 3-formyl-2,4-dihydroxy-6-methylbenzoate -5.6 
Lobaric acid -5.6 
 
The compounds in the order of the lowest to the highest ∆G values are Atranorin (-7.0 
Kcal/mol), Lobarin (-6.7 Kcal/mol), Methyl 2,4-dihydroxy-3,6-dimethylbenzoate (5.9 Kcal/mol), 
Methyl 3‐formyl‐2,4‐dihydroxy‐6‐methylbenzoate (-5.9 Kcal/mol), Ethyl 3-formyl-2,4-dihydroxy-6-
methylbenzoate (-5.6 Kcal/mol), and Lobaric acid (-5.6 Kcal/mol). Therefore, among these 
compounds, Atranorin has the best stability.  
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The best compound that can inhibit receptors by spontaneously forming bonding energy was 
selected according to the lowest Gibbs free energy. Based on the results of the study, Atranorin had the 
lowest Gibbs free energy (-7.0 kcal/mol) among the other test ligands.  Hydrogen bonding is an 
interaction that occurs between two molecules, each acting as a donor and an acceptor. Hydrogen 
bonds are formed as hydrogen binds atoms like fluorine (F), nitrogen (N), and oxygen (O) (Głowacki 
et al., 2013).   
Root Mean Square Deviation (RMSD) was calculated to quantify the experimental value that 
evaluates whether or not the docking program can produce a pose that is close to the native 
conformation. A real-native conformation is achieved if RMSD relative to the native pose is ≤ 2.0 Å 
(Bell and Zhang, 2019). At this state, the docking poses produced are expected to have the lowest 
RMSD cut-off value ≤ 2.0 Å (Angstrom). 
As visualized and calculated using the Discovery Studio program, the hydrogen bonding 
between the test ligand and amino acid residues at the receptor was indicated by a green line. The 
identified ligand-receptor interactions are presented in Table 5. 
Table 5. The ligand-receptor interactions and number of hydrogen bonding 
 in compounds isolated from Stereocaulon halei 
Compounds Hydrogen 
Bonding 
Amino acids and 
functional groups  





























Apart from the formation of hydrogen bonds between ligands with protein, visualization using 
the Discovery Studio 2016 also displayed any amino acid residues involved in hydrophobic 
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Table 6. Amino acid residues of the compounds isolated from Stereocaulon halei  
that are involved in hydrophobic interactions with ligands 
Compounds Amino Acid Residues 
Lobarin GLN556. LYS575. SER487. TYR448. 
TYR560. TYR60 




ARG328. ARG332. ALA392 ASP173. 
GLU391. GLY397. GLU394. ILE401. 




ARG332. ALA392. ASP173. 
ILE401.GLU394. GLY397. VAL402 
Ethyl 3-formyl-2,4-dihydroxy-6-
methylbenzoate 
TRP563. ILE401. ARG332. ARG328 
Lobaric acid ALA509. GLU553. ILE496. LEU495. 
PHE550. SER594. VAL586 
 
CONCLUSIONS  
Lobarin does not fulfill the requirements of the Egan and Muegge’s drug-likeness. The 
compounds isolated from Stereocaulon halei are Atranorin, Lobarin, Methyl 2,4-dihydroxy-3,6-
dimethylbenzoate, Methyl 3‐formyl‐2,4‐dihydroxy‐6‐methylbenzoate, Ethyl 3-formyl-2,4-dihydroxy-
6-methylbenzoate, and Lobaric acid, with the Gibbs free energy of -7.0, -6.7, -5.9, -5.9, -5.6, and -5.6 
kcal/mol, respectively. Based on the results of screening and visualization between the ligand and the 
protein, the general interactions that occur are in the form of hydrogen bonds and hydrophobic 
interactions. Further research is required so as to find out other parameters and the active site of the 
enzyme that a good inhibitor must have and to determine the stability of the ligand-protein bonds, 
especially in Atranorin.  
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